Article Text

Download PDFPDF
ROCK inhibitors for the treatment of ocular diseases
  1. Ramin Nourinia1,
  2. Shintaro Nakao2,3,
  3. Souska Zandi3,4,
  4. Sare Safi1,
  5. Ali Hafezi-Moghadam3,
  6. Hamid Ahmadieh1
  1. 1 Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2 Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  3. 3 Center for Excellence in Functional and Molecular Imaging, Brigham and Women’s Hospital, Harvard University, Boston, Massachusetts, USA
  4. 4 Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Berner Augenklinik am Lindenhofspital, Bern, Switzerland
  1. Correspondence to Dr Hamid Ahmadieh, Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran 16666, Iran; hahmadieh{at}hotmail.com

Footnotes

  • Contributors RN, AHM, HA: conceptualisation, methodology, writing–original draft preparation, writing–review and editing. SN, SZ: conceptualisation, methodology, writing–review and editing. SS: methodology, writing–review and editing.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors RN, AHM, HA: conceptualisation, methodology, writing–original draft preparation, writing–review and editing. SN, SZ: conceptualisation, methodology, writing–review and editing. SS: methodology, writing–review and editing.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.